Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Hematology/Oncology Clinics of North America|June 23, 2023
Toxicity Management of Systemic Kidney Cancer TherapiesQian Qin, Ellen Nein, Andrea Flaten, et al.Scientific Reports|February 15, 2019
Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growthMatanel Yheskel, Ronak Lakhia, Patricia Cobo-Stark, et al.American Journal of Physiology. Renal Physiology|September 15, 2017
PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in miceRonak Lakhia, Matanel Yheskel, Andrea Flaten, et al.Nature Communications|May 28, 2025
An RNA transmethylation pathway governs kidney nephrogenic potentialHarini Ramalingam, Jesus Alvarez, Andrea Flaten, et al.Nature Communications|August 14, 2022
PKD1 and PKD2 mRNA cis-inhibition drives polycystic kidney disease progressionRonak Lakhia, Harini Ramalingam, Chun-Mien Chang, et al.JCI Insight|March 18, 2020
Interstitial microRNA miR-214 attenuates inflammation and polycystic kidney disease progressionRonak Lakhia, Matanel Yheskel, Andrea Flaten, et al.Cell Metabolism|April 14, 2021
A methionine-Mettl3-N6-methyladenosine axis promotes polycystic kidney diseaseHarini Ramalingam, Sonu Kashyap, Patricia Cobo-Stark, et al.Nature Communications|September 14, 2019
Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney diseaseEdmund C Lee, Tania Valencia, Charles Allerson, et al.Nature Communications|February 17, 2017
microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolismSachin Hajarnis, Ronak Lakhia, Matanel Yheskel, et al.Pageof 1